Mesna is a pharmaceutical active ingredient used to reduce the risk of bladder bleeding in patients receiving cyclophosphamide or ifosfamide. It is administered orally or intravenously.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 19767-45-4
N-acetyl-L-glutamate(S)-3-methyl-1-(2-piperidinophenyl)-1-butylamine
pharmaceutical raw material
Sodium chenodeoxycholate
pharmaceutical raw material
(-)-homoharringtonine
pharmaceutical raw material
Mebeverine hydrochloride
pharmaceutical raw material
Loxapine
pharmaceutical raw material
Amiodarone hydrochloride
pharmaceutical raw material
Trilaciclib dihydrochloride
pharmaceutical raw material
(2S)-4-Amino-N-{(1R,2S,5S)-5-amino-4-[(6-amino-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-2-[(3-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
pharmaceutical raw material
sodium 2-sulfanylethanesulfonate
XOGTZOOQQBDUSI-UHFFFAOYSA-M
C(CS(=O)(=O)[O-])S.[Na+]